» Articles » PMID: 27113335

Factors Associated with Initiation of Antiretroviral Therapy in the Advanced Stages of HIV Infection in Six Ethiopian HIV Clinics, 2012 to 2013

Overview
Journal J Int AIDS Soc
Date 2016 Apr 27
PMID 27113335
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Most HIV-positive persons in sub-Saharan Africa initiate antiretroviral therapy (ART) with advanced infection (late ART initiation). Intervening on the drivers of late ART initiation is a critical step towards achieving the full potential of HIV treatment scale-up. This study aimed to identify modifiable factors associated with late ART initiation in Ethiopia.

Methods: From 2012 to 2013, Ethiopian adults (n=1180) were interviewed within two weeks of ART initiation. Interview data were merged with HIV care histories to assess correlates of late ART initiation (CD4+ count <150 cells/µL or World Health Organization Stage IV).

Results: The median CD4 count at enrollment in HIV care was 263 cells/µL (interquartile range (IQR): 140 to 390) and 212 cells/µL (IQR: 119 to 288) at ART initiation. Overall, 31.2% of participants initiated ART late, of whom 85.1% already had advanced HIV disease at enrollment. Factors associated with higher odds of late ART initiation included male sex (vs. non-pregnant females; adjusted odds ratio (aOR): 2.02; 95% CI: 1.50 to 2.73), high levels of psychological distress (vs. low/none, aOR: 1.96; 95% CI: 1.34 to 2.87), perceived communication barriers with providers (aOR: 2.42, 95% CI: 1.24 to 4.75), diagnosis via provider initiated testing (vs. voluntary counselling and testing, aOR: 1.47, 95% CI: 1.07 to 2.04), tuberculosis (TB) treatment prior to ART initiation (aOR: 2.16, 95% CI: 1.43 to 3.25) and a gap in care of six months or more prior to ART initiation (aOR: 2.02, 95% CI: 1.10 to 3.72). Testing because of partner illness/death (aOR: 0.64, 95% CI: 0.42 to 0.95) was associated with lower odds of late ART initiation.

Conclusions: Programmatic initiatives promoting earlier diagnosis, engagement in pre-ART care, and integration of TB and HIV treatments may facilitate earlier ART initiation. Men and those experiencing psychological distress may also benefit from targeted support prior to ART initiation.

Citing Articles

Time to initiation of antiretroviral therapy and its predictors among newly diagnosed HIV positive at the selected public health centers in Adama Town, Ethiopia.

Girma Y, Mannekulih E, Lemi H, Charkos T AIDS Res Ther. 2025; 22(1):33.

PMID: 40069857 PMC: 11895298. DOI: 10.1186/s12981-025-00703-1.


Treatment failure among Sub-Sahara African children living with HIV: a systematic review and meta-analysis.

Walle B, Tiruneh C, Wubneh M, Chekole B, Kassaw A, Assefa Y Ital J Pediatr. 2024; 50(1):202.

PMID: 39354602 PMC: 11446064. DOI: 10.1186/s13052-024-01706-w.


Barriers and enabling structural forces affecting access to antiretroviral therapy in Nigeria.

Oturu K, OBrien O, Ozo-Eson P BMC Public Health. 2024; 24(1):105.

PMID: 38184516 PMC: 10770989. DOI: 10.1186/s12889-023-17271-6.


Factors associated with late initiation of antiretroviral therapy in Iran's HIV/AIDS surveillance data.

Sharafi M, Mirahmadizadeh A, Hassanzadeh J, Seif M, Heiran A Sci Rep. 2024; 14(1):199.

PMID: 38167855 PMC: 10761711. DOI: 10.1038/s41598-023-50713-0.


Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review.

SeyedAlinaghi S, Afsahi A, Moradi A, Parmoon Z, Habibi P, Mirzapour P AIDS Res Ther. 2023; 20(1):74.

PMID: 37884997 PMC: 10604802. DOI: 10.1186/s12981-023-00572-6.


References
1.
Aday L, Andersen R . A framework for the study of access to medical care. Health Serv Res. 1974; 9(3):208-20. PMC: 1071804. View

2.
Mulissa Z, Jerene D, Lindtjorn B . Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia. PLoS One. 2010; 5(10):e13268. PMC: 2952597. DOI: 10.1371/journal.pone.0013268. View

3.
Galdas P, Cheater F, Marshall P . Men and health help-seeking behaviour: literature review. J Adv Nurs. 2005; 49(6):616-23. DOI: 10.1111/j.1365-2648.2004.03331.x. View

4.
Gadisa T, Tymejczyk O, Kulkarni S, Hoffman S, Lahuerta M, Remien R . Disclosure History Among Persons Initiating Antiretroviral Treatment at Six HIV Clinics in Oromia, Ethiopia, 2012-2013. AIDS Behav. 2016; 21(1):70-81. PMC: 4949152. DOI: 10.1007/s10461-016-1290-4. View

5.
Krentz H, Auld M, Gill M . The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection. HIV Med. 2004; 5(2):93-8. DOI: 10.1111/j.1468-1293.2004.00193.x. View